CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 10-Q Report Quarterly Report
- 8-K/A Event Other events
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Other events
- 8-K Event Material agreement
- 4 Open-market buy 10% owner bought 35,000 shares at $7.90 ($276,500)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 410,000 shares at an average $8.00 ($3,280,198)
- 4 Open-market buy 10% owner bought 2,801 shares at $8.00 ($22,408)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 6,281 shares (grant or award)
- 4 Grant or award Director acquired 6,281 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
Page 30 of 44 · 872 filings